Oramed grants Daniel Aghion 72.8K-share Board award
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Oramed Pharmaceuticals Inc. (ORMP) director Daniel Aghion received two restricted stock awards on November 12, 2026: 72,780 shares for fiscal years 2027 and 2028 annual Board awards, and 2,890 shares for fiscal year 2027 committee awards, under the Amended and Restated 2019 Stock Incentive Plan. The Board award vests in two 36,390-share tranches, each in 12 substantially equal quarterly installments beginning April 1, 2027, and April 1, 2028, respectively. The committee award vests in four substantially equal quarterly installments beginning April 1, 2027. Vesting of both awards is subject to continued service.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock F1 | 72,780 | -- | -- |
| Grant/Award | Common Stock F2 | 2,890 | -- | -- |
Footnotes (2)
- F1. On November 12, 2026, the issuer granted to the reporting person a restricted stock award of 72,780 shares under the issuer's Amended and Restated 2019 Stock Incentive Plan, representing the reporting person's annual Board awards for fiscal years 2027 and 2028. Of these shares, 36,390 vest in twelve substantially equal quarterly installments beginning April 1, 2027, and 36,390 vest in twelve substantially equal quarterly installments beginning April 1, 2028, in each case subject to the reporting person's continued service. No annual Board award will be granted to the reporting person for fiscal year 2028.
- F2. On November 12, 2026, the issuer granted to the reporting person a restricted stock award of 2,890 shares under the issuer's Amended and Restated 2019 Stock Incentive Plan, representing the reporting person's fiscal year 2027 committee awards, which vest in four substantially equal quarterly installments beginning April 1, 2027, subject to the reporting person's continued service.
Key Figures
Key Terms
restricted stock award financial
Amended and Restated 2019 Stock Incentive Plan financial
substantially equal quarterly installments financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
When do Daniel Aghion’s ORMP stock awards vest?
Will Daniel Aghion receive an ORMP annual Board award for fiscal year 2028?
AI-generated analysis. How Rhea-AI works. Not financial advice.